Recurring concern
Unsafe lithium treatment management
First reported 12 Jan 2018•Latest report 12 Oct 2023
What this concern includes
Includes deficiencies in the end-to-end management of lithium treatment, including prescribing, dispensing, required blood-test monitoring, communication of results or advice, and timely clinical response to lithium-related risks.
Not included
- Excludes failures involving medical attention or medication management that are not specifically related to lithium treatment.
- Excludes deficiencies concerning unrelated medicines or general healthcare provision.
- Excludes isolated generic communication, staffing or documentation failures unless they are directly tied to the safe management of lithium treatment.
- Reports
- 2
- Individual concerns
- 3
- Date range
- 2018–2023
- Stated actions
- 4
Distinct published reports
A report can raise multiple concerns
First to latest report issue date
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
-
Concerns raised1
Failure to provide basic medical attention in relation to lithium prescribing and dispensing
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.3
-
Action
Register Norman Lodge patients as temporary residents so their home practices remain involved in care.
Stated by Low Moor Medical Practice -
Action
Ensure clinical pharmacists identify medications, including shared-care medicines, that must be issued without interruption.
Stated by Low Moor Medical Practice -
Action
Discuss with the local pathology laboratory receiving lithium results as individual results rather than within broader biochemistry lists.
Stated by Low Moor Medical Practice
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.1
-
Position
Shared-care drugs and intermediate-care units fall outside core general practice and are covered by Local Enhanced Services.
Stated by Low Moor Medical Practice
-
Concerns raised2
Failure to complete quarterly kidney function and lithium-level monitoring
Failure of clinical alert processes to reflect applicable lithium monitoring guidelines
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.1
-
Action
Highlight lithium monitoring requirements to GPs and practices and remind them that current BNF and local CCG prescribing guidance is available.
Stated by NHS England
Data last updated 7 September 2026